Terry A Wallace

Array ( [id] => 575052 [patent_doc_number] => 07459474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Modulators of the glucocorticoid receptor and method' [patent_app_type] => utility [patent_app_number] => 10/865443 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15015 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459474.pdf [firstpage_image] =>[orig_patent_app_number] => 10865443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352247 [patent_doc_number] => 20040248957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Heterocyclic compounds and uses thereof' [patent_app_type] => new [patent_app_number] => 10/848521 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16534 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248957.pdf [firstpage_image] =>[orig_patent_app_number] => 10848521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906234 [patent_doc_number] => 20050101629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/845012 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20058 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101629.pdf [firstpage_image] =>[orig_patent_app_number] => 10845012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040566 [patent_doc_number] => 20050159419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage' [patent_app_type] => utility [patent_app_number] => 10/844949 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28212 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159419.pdf [firstpage_image] =>[orig_patent_app_number] => 10844949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089743 [patent_doc_number] => 20050009856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Treatment of dyskinesia' [patent_app_type] => utility [patent_app_number] => 10/819345 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4116 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009856.pdf [firstpage_image] =>[orig_patent_app_number] => 10819345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426356 [patent_doc_number] => 20040229800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Compositions and methods for promoting nerve regeneration' [patent_app_type] => new [patent_app_number] => 10/805139 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18989 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229800.pdf [firstpage_image] =>[orig_patent_app_number] => 10805139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265061 [patent_doc_number] => 20040242597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Combination' [patent_app_type] => new [patent_app_number] => 10/489920 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12388 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242597.pdf [firstpage_image] =>[orig_patent_app_number] => 10489920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172865 [patent_doc_number] => 20050203115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Narcotic-NSAID ion pairs' [patent_app_type] => utility [patent_app_number] => 10/796308 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34380 [patent_no_of_claims] => 160 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203115.pdf [firstpage_image] =>[orig_patent_app_number] => 10796308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196847 [patent_doc_number] => 07638510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders' [patent_app_type] => utility [patent_app_number] => 10/545411 [patent_app_country] => US [patent_app_date] => 2004-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3213 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638510.pdf [firstpage_image] =>[orig_patent_app_number] => 10545411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 739837 [patent_doc_number] => 07029659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Mousse composition' [patent_app_type] => utility [patent_app_number] => 10/766202 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3256 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029659.pdf [firstpage_image] =>[orig_patent_app_number] => 10766202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677062 [patent_doc_number] => 20040152764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Compositions and methods for the prevention and treatment of cerebral ischemia' [patent_app_type] => new [patent_app_number] => 10/762183 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19704 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152764.pdf [firstpage_image] =>[orig_patent_app_number] => 10762183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343831 [patent_doc_number] => 20040191898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse' [patent_app_type] => new [patent_app_number] => 10/746049 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26997 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191898.pdf [firstpage_image] =>[orig_patent_app_number] => 10746049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306212 [patent_doc_number] => 20040116443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Dopamine D4 ligands for the treatment of novelty-seeking disorders' [patent_app_type] => new [patent_app_number] => 10/731265 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12121 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116443.pdf [firstpage_image] =>[orig_patent_app_number] => 10731265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473953 [patent_doc_number] => 20040121988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Treatment of cerebrovascular disease' [patent_app_type] => new [patent_app_number] => 10/729276 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14589 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121988.pdf [firstpage_image] =>[orig_patent_app_number] => 10729276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428037 [patent_doc_number] => 20040229948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method for preventing hepatic encephalopathic episodes' [patent_app_type] => new [patent_app_number] => 10/725064 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2729 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229948.pdf [firstpage_image] =>[orig_patent_app_number] => 10725064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151408 [patent_doc_number] => 20040171691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Propofol with cysteine' [patent_app_type] => new [patent_app_number] => 10/695291 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6825 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171691.pdf [firstpage_image] =>[orig_patent_app_number] => 10695291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913793 [patent_doc_number] => 20060128810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Remedies for allergic diseases' [patent_app_type] => utility [patent_app_number] => 10/530752 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12041 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128810.pdf [firstpage_image] =>[orig_patent_app_number] => 10530752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291195 [patent_doc_number] => 20040110769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Farnesyl protein transferase inhibitor combinations with antiestrogen agents' [patent_app_type] => new [patent_app_number] => 10/468162 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11212 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110769.pdf [firstpage_image] =>[orig_patent_app_number] => 10468162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387389 [patent_doc_number] => 20040029906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Inhibitors of dna polymerase sigma' [patent_app_type] => new [patent_app_number] => 10/343563 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7749 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029906.pdf [firstpage_image] =>[orig_patent_app_number] => 10343563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387672 [patent_doc_number] => 20040029942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Compounds and methods for use thereof in the treatment of viral infections' [patent_app_type] => new [patent_app_number] => 10/634542 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11962 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029942.pdf [firstpage_image] =>[orig_patent_app_number] => 10634542 [rel_patent_id] =>[rel_patent_doc_number] =>)